Claudia Lundgren
Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Henrik Lindman
- E-post:
- claudia.lundgren@igp.uu.se
- Besöksadress:
- Akademiska sjukhuset, ing 100/101, plan 1
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ing 100/101
751 85 Uppsala
- Akademiska meriter:
- Leg.läk.
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer (2023)
- Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53) (2022)
- High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers (2017)
- Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer (2015)
- High Expression of Cyclin E Increases the Risk for Breast Cancer Death by 2-3 Fold in Node Negative Breast Cancer Patients (2009)
Alla publikationer
Artiklar
- Whole-body MRI surveillance in TP53 carriers is perceived as beneficial with no increase in cancer worry regardless of previous cancer (2023)
- Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53) (2022)
- High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers (2017)
- Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer (2015)